Find your path to Steve
471 people in our graph share verified history with Steve — schools, employers, funds. One of them is your warm intro.
Sam BlackmanunlockedSteve: together at Children's Hospital of Philadelphia (2008–2010)
×6Steve: together at Stealth Startup
Steve: together at Case Western Reserve University School of Medicine
×4Steve: together at Case Western Reserve University
About
Dr. Steven M. Altschuler is Managing Director of Healthcare Ventures at Ziff Capital Partners, where he leads efforts to form companies at the intersection of machine learning and cellular and molecular sciences, and has led investments including Affinivax, which was acquired by GSK for $3.3 billion. He cofounded Spark Therapeutics and served as its board chair from its founding through its transition to a public company and the 2017–18 approval of LUXTURNA, a gene therapy for RPE65-associated inherited blindness; the company was acquired by Roche Holding AG for $4.8 billion in December 2019. He has also served as board chair of Lexeo Therapeutics, Avista, ViaNautis, and Satellite Bio.
Executive Chair at Port Therapeutics
Intro paths
→
In turn, Steve can intro founders to Port Therapeutics's investors below.
Port Therapeutics's investors · 1
Experience
- Stealth StartupCEOcurrent2026 — present
- 89bioChair Of The Board Of Directorscurrent2020 — presentSan Francisco, CA
- Ziff Capital PartnersManaging Director-Healthcare Venturecurrent2018 — presentNew York, New York
- Stellular BioMember Board Of Directorscurrent2019 — presentWatertown, Mass
- ImVaX IncMember Board Of Directorscurrent2019 — presentGreater Philadelphia Area
- Weight WatchersMember Board Of Directorscurrent2012 — presentNew York, New York
- AsclepiX Therapeutics IncChair Of The Board Of Directors2019 — 2026Baltimore, Maryland Area
- Adtalem Global EducationMember Board Of Directors2018 — 2020Greater Chicago Area
- Spark Therapeutics, Inc.Chair, The Board Of Directors2013 — 2019Philadelphia, Pennsylvania
- University of Miami and Health SystemExecutive Vice President and CEO2016 — 2017
- Mead Johnson NutritionMember Board Of Directors2009 — 2017Greater Chicago Area
- Children's Hospital of PhiladelphiaPresident and CEO2000 — 2015
Skills & more
Strategic PlanningLeadershipPublic SpeakingBiotechnology1Entrepreneurship1Board of DirectorsBusiness DevelopmentHealthcare9Healthcare ManagementNonprofits2
From Steve's professional profile.
Frequently asked questions
- Who is Steve Altschuler?
- Dr. Steven M. Altschuler is Managing Director of Healthcare Ventures at Ziff Capital Partners, where he leads efforts to form companies at the intersection of machine learning and cellular and molecular sciences, and has led investments including Affinivax, which was acquired by GSK for $3.3 billion. He cofounded Spark Therapeutics and served as its board chair from its founding through its transition to a public company and the 2017–18 approval of LUXTURNA, a gene therapy for RPE65-associated inherited blindness; the company was acquired by Roche Holding AG for $4.8 billion in December 2019. He has also served as board chair of Lexeo Therapeutics, Avista, ViaNautis, and Satellite Bio.
- Where does Steve Altschuler work?
- Steve Altschuler is Executive Chair at Port Therapeutics.
- Where did Steve Altschuler go to school?
- Steve Altschuler studied at Case Western Reserve University School of Medicine (Doctor of Medicine - MD, Medicine); Case Western Reserve University (Bachelor of Arts - BA, Mathematics and Statistics).
Same school
Also attended Case Western Reserve University School of Medicine22
Richard RansohoffVenture Partner at Third Rock VenturesTodd PonskyChief Innovation Officer at Flare Capital PartnersTarek El-SawyVenture Partner at RaivenGlenn PierceScientific Advisory Group Co-Chair at Pathway to CuresKingsley R. ChinManaging Partner at KIC VenturesSteven SchachterAdvisor, Medtech at Iaso Ventures
+ 16 more
Also attended Case Western Reserve University134
Will BruneSenior Associate at Mutual Capital PartnersKT MooreAdvisor at Clear VenturesPete KoomenGeneral Partner at Y CombinatorAsheem ChandnaPartner at Greylock focused on enterprise, cybersecurity, and infrastructure softwareMatt SteinChief Information Officer at Flare Capital PartnersKaren SpilizewskiBiomedical engineer helping accelerate life science technologies from development into the marketplace
+ 128 more
Shared employers
Also worked at Stealth Startup482
Andrew ChenGeneral Partner at Andreessen HorowitzGabriel PereyraCo-founder & President of HarveyErica VanInvestment Director at Intel CapitalHemamAdvisor at Clear VenturesArhaan A.Deeptech Fellow at Clear VenturesHamish GarnettAssociate at Manta Ray Ventures
+ 476 more
Also worked at AsclepiX Therapeutics Inc3
Also worked at Adtalem Global Education3
Also worked at Spark Therapeutics, Inc.8
Jason GabrielManaging Director at Syngenta Group VenturesNick OlsenPrincipal at Innovation EndeavorsEgen AtkinsonManaging Partner at Commodore CapitalJeff MarrazzoFounder at Dispatch BiotherapeuticsKatherine HighCEO at RhyGaze AGLauren KaskielExecutive Officer at Code Biotherapeutics
+ 2 more